Else Successfully Completes Second Preclinical Study on the Path For FDA Approval of World's First Whole Plant, Soy-Free Infant Formula
apnews.com
politics
2022-05-31 11:03:41

With products for toddlers and kids already in the market, Else has made tremendous progresstowards becoming a player in the $80 billion global infant formula market.VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. ( BABY ) ( BABYF ) ( 0YL.F ) ('Else' or the 'Company'), the Plant-Based baby, toddler, and children nutrition company, is pleased to announce that it has concluded a second successful preclinical study on its Plant-Based infant formula, which is a crucial phase for bringing the Company's innovative 0-12 month infant formula to market.
